What Happens When You Stop Taking Semaglutide or Tirzepatide in 2026

What happens when you stop taking semaglutide or tirzepatide is fairly predictable. When the medicine clears your body, appetite and food noise tend to return, and some weight often comes back. In two large trials, people regained much of their loss within a year of stopping. You can lower that risk with a physician-guided step-down, a possible maintenance dose, and strong daily habits. Here's what the research shows and how to plan your off-ramp.

What happens when you stop a GLP-1

When you stop semaglutide or tirzepatide, the appetite signal it was sending fades over a few weeks. Hunger and food noise usually return to where they were before, and many people regain part of the weight they lost. This is a biology response, not a willpower failure. It happens because these medicines manage appetite while you take them; they don't reset your body's set point for good.

• Appetite and cravings tend to come back within weeks of the last dose.
• Some weight regain is common, and trials help predict how much.
• A slow taper plus strong habits can soften the rebound.
• A lower maintenance dose is an option some people use instead of a full stop.

Why weight tends to come back after stopping

Weight returns because the medicine's effect on appetite ends when the drug leaves your system. Semaglutide and tirzepatide act like GLP-1, a hormone that quiets hunger and slows how fast your stomach empties. While you take it, you eat less without fighting cravings all day. Stop, and that help goes away, so appetite climbs back toward its old level.

Your body also defends its old weight. After weight loss, hunger hormones can run higher and calorie burn can run a bit lower, which nudges weight back up. That's why a plan for the months after stopping matters as much as the medicine itself. See our GLP-1 weight loss timeline for how this plays out over the full course.

What the research shows about weight regain

Two large trials tracked what happens after people stop. Both found meaningful regain within a year, and both found that people who stayed on treatment kept more of their loss. The numbers below are research findings, not a promise about any one person.

The takeaway is consistent: stopping tends to reverse part of the progress, and staying on some form of treatment tends to preserve more of it. Withdrawal also partly reversed the blood-pressure and blood-sugar improvements in both trials. This is why many physicians frame obesity care as long-term, like managing blood pressure, rather than a short course.

Common reasons people come off a GLP-1

People stop for practical reasons, not just because they hit a goal. Knowing your reason helps you and your physician pick the right off-ramp.

• Reached a weight or health goal and want to try holding it.
• Cost or insurance changes made refills hard.
• Side effects like nausea that didn't settle.
• Supply gaps or wanting a planned break.
• Pregnancy planning or another medical reason (always physician-led).

How to come off: taper, don't just stop

The safer path is a gradual step-down guided by your physician, not an abrupt stop. There's no single official taper protocol yet, and no large trial has tested one, so this is individualized. Many clinicians step the dose down in the same increments used going up, giving appetite time to return slowly instead of all at once.

• Work the plan with your prescriber, not on your own.
• Step down in stages rather than dropping the full dose at once.
• Hold each lower step for a few weeks and watch hunger and weight.
• Lean harder on protein, fiber, and resistance training as appetite returns.
• Have a check-in scheduled so you can adjust if weight starts climbing.

Maintenance dosing and microdosing

Coming off doesn't have to mean going to zero. Some people move to a lower maintenance dose to hold their loss with less medicine, rather than stopping fully. Because the trials show regain is tied to losing the appetite effect, keeping some of that effect is one way to protect progress.

• Maintenance dose: the lowest dose that keeps appetite steady and weight stable.
• Microdosing: smaller, less frequent amounts some people use to ease off; see GLP-1 microdosing.
• Pause and reassess: stop, watch closely, and restart if weight rebounds.
• If you've hit a stall on treatment, that's a different problem; see handling a weight-loss plateau.

There's no one right choice. What fits depends on your goal, your side-effect history, and cost. Your physician confirms whether a maintenance approach makes sense for you; you decide the direction you want to head.

Food noise and hunger after stopping

Expect food noise to return, and plan for it. Food noise is the constant background chatter about eating that GLP-1s quiet down. When the medicine fades, that chatter usually comes back, which is often the first sign appetite is climbing again. Knowing it's coming helps you meet it with structure instead of surprise.

Build guardrails before the noise returns: regular meals, protein first, and less easy access to snacks. Our guide to managing food noise covers practical tactics. If you find hunger becomes hard to manage after stopping, that's worth a conversation with your physician about a maintenance dose.

Habits that help you hold the loss

Habits do the heavy lifting once the medicine steps back. In both trials, the people who held more of their loss paired treatment with strong routines. The four that matter most protect muscle and keep appetite honest.

• Protein at every meal to protect muscle and stay full longer.
• Resistance training two to three times a week; see protecting muscle on a GLP-1.
• Fiber-rich foods and steady meal timing instead of grazing.
• Regular weigh-ins so a small regain doesn't become a large one.
• Sleep and stress care, since both drive hunger.

None of this replaces the medicine's appetite help, but it's what keeps the loss from unraveling. The goal is a routine sturdy enough to stand on once the dose is lower or gone.

How pru handles coming off a GLP-1

Planning your off-ramp instead of quitting cold is a proactive move, and it's the one that tends to protect your progress. pru is a telehealth platform for compounded peptides, built for the long game rather than a quick course. A licensed physician reviews your history and confirms whether continuing, tapering, or a maintenance dose fits you. You choose the direction; the physician confirms the clinical fit and doesn't pick the medicine for you. Prescriptions are filled by FDA-regulated 503A compounding pharmacies.

• Live weight-loss options: pharmacy-grade compounded semaglutide and compounded tirzepatide.
• Membership is about $50/mo; the peptide is billed at cost, itemized, with no member markup. A higher dose costs a little more, never a markup.
• A maintenance or step-down dose is a physician conversation, so you're not choosing between quitting cold and paying full price to stay on.
• See pricing and the full weight loss and metabolism catalog.

A note on the newer drugs people ask about: retatrutide and cagrilintide are still investigational, not FDA-approved, and not available as legitimate compounded products. pru does not offer them, and grey-market vials sold as "research-grade" skip the physician and the regulated pharmacy entirely.

If you want a compliant path, the compounded semaglutide and tirzepatide above are what pru offers. pru can't promise a specific amount of weight loss or that you'll keep it off; what it offers is physician oversight and regulated fills, and pru exists to make that smart, informed path the accessible one when you're ready to take the next step.

Related reading

• GLP-1 weight loss timeline: what to expect month by month
• GLP-1 microdosing: what it is and who it's for
• Managing food noise on and off a GLP-1
• Protecting muscle while losing weight
• Semaglutide vs tirzepatide: how they compare
• Where to buy compounded GLP-1 safely

Common questions